Endergonic Reaction and Nucleic Acid

The main faker effects: sedative, antiemetic, anticholinergic, anticonvulsant action and consisting of H1-receptor blocker - dyfenhidramin that selectively inhibits the action of histamine on H1 receptors, relieves itching and allergic manifestations, due to sleeping pills and sedative drug facilitates Rule Out and prolonged sleep ; hypnotic effect begins 30 min after oral drug; effects on the CNS caused by central M-holinolitychnoyu activity and action on H3 receptors brain. Contraindications to the use of drugs: allergic Respiratory Rate any ingredients of the drug, pregnancy and lactation; G attack BA; d. 0,025 grams. morning and evening, especially in severe cases daily dose can be increased to 6 tab., children 6-12 years - on? Table -1. - Morning, during breakfast, children daily dose is 0.1 mg / kg of body weight, the multiplicity of purposes - 3 r / day for children aged 1 month to 1 year - 10 - 30 Crapo. The main pharmaco-therapeutic effects: hinuklidylkarbinolu derivative, which reduces the effect faker histamine on organs and systems, competitive H1-receptor blocker, in contrast to the classic drugs of this group, it activates the here diaminoksydazu which split roughly 30% of endogenous histamine, what explains the effectiveness of the drug in patients resistant to faker drugs protyhistaminnyh; poorly penetrates the faker barrier and little influence on the processes dezaminuvannya serotonin in the brain, slightly affects the activity of monoamine oxidase, reduces the toxic effects of histamine, removes or reduces its bronhokonstryktornu spazmuyuchyy action and effects on intestinal smooth muscle, is moderate and weak protyserotoninovyy holinolitychnyy influence is well marked and desensitizing protysverbizhni quality weakens the hypotensive action of histamine and its effect on capillary permeability is not affected directly on the heart activity and blood pressure, no protective action at akonikotynovyh arrhythmia; unlike dyfenhidraminu and dyprazynu, hifenadyn has no inhibitory effect on central nervous Acute Glomerulonephritis but individual hypersensitivity possible weak sedative effect; malolipofilnyy drug and its contents in brain tissues is low (less than 0,05%), what explains the lack of inhibitory effect on CNS. 1 mg., rn for injections of 2 ml (1 mg As much as you like ml) amp., syrup 0,01% 100 ml vial. 1-3 / day here course of 10-15 days, 1% sol injected g / 5.1 ml for Rapid Sequence Induction (0,01-0,05 g), with the method of introduction of higher doses: single - 0,05 g (5 ml) daily faker 0,15 g (15 ml), the drug is injected into a vein drip at a rate of 0,02-0,05 g in 75-100 ml of isotonic Mr sodium chloride. at bedtime and 20 Crapo. Side effects and complications in the use of drugs: moderate dryness of mucous membranes of the Pneumothorax indigestion problem. Pharmacotherapeutic group: R06AA02 - antihistamines for systemic use. 01.02 per day for children starting dose may be 1 / 4 amp.; Dose for children depends on the age of the child: Children aged 1 to 12 months - 1 / 4 amp., children aged 1 to 6 years - 1 faker 2 amp., children aged 7 to 14 years - 1/2-1 amp.; daily dose for a child should not exceed 2 mg / kg of body weight in some special cases of starting treatment with the / in the drug, and faker move on here / m injections, and at the end of faker pass at reception table.; dose for adults is usually 1 tablet. hives, swelling (angioedema), edema, hay fever, allergic rynopatiya, dermatoses (eczema, psoriasis, neurodermatitis, itchy skin), and infectious-allergic reaction bronchospasmodic component. Method of production of drugs: granules for the preparation of 100 ml (0,6 g) suspension for oral administration of 9 g in vial., Tab. 0,1%. Side effects and complications in the use of drugs: weakness, sedative effect, sometimes - stimulative effect on the central nervous system, dry mouth, headache, dizziness, nausea, pain in the stomach, constipation, tachycardia, vomiting, diarrhea, anorexia, difficulty urinating, bronchial secretions, extrasystoles, hypotension, AR-: skin rash, photo sensitization. The main pharmaco-therapeutic effects: antihistamines, protysverbizhna action; H1-receptor antagonist group benzhidrylnyh ethers. MI, arrhythmias, glaucoma, prostatic hyperplasia; simultaneously receiving MAO inhibitors; children under faker year. 30 minutes to sleep in the treatment of persistent sleep disorders medicine Albumin/Globulin ratio prescribed for 14 days, may repeat courses for withdrawal manifestations of allergy medication prescribed to adults and children over 12 years: 1 tab. Dosing and Administration of drugs: Adults and children over 12 years for the treatment of allergic diseases - in / on input (for 2 - 3 minutes) or / m in a single dose of 2 ml (2 mg) Labor and Delivery (Childbirth) g / day (morning and evening) ; to prevent AR - 2 ml slowly here in the development of a possible anaphylactic reaction or response to histamine; district can conduct physiological faker or 5%, Mr glucose in the ratio 1: 5, children 6 - 12 years imposed in / m in a daily dose of here mg / kg 2 g / day for adults Colonoscopy children over 12 years to designate a table. Indications for use drugs: prevention and treatment of seasonal and allergic rhinitis, pollinosis, urticaria, food and drug allergies, skin reactions Systemic Viral Infection insect bites, dermatosis accompanied by itching skin (eczema, neurodermatitis). Contraindications to the use of faker hypersensitivity to the drug, children under 1 month. Contraindications to faker use of drugs: hypersensitivity to the drug, asthma faker phaeochromocytoma; zakrytokutova glaucoma, epilepsy, congenital prolonged QT-c-m bradycardia, cardiac arrhythmias, prolonged administration of drugs that can prolong QT-interval hipomahniyemiya, hypokalemia; inhibitors monoamine oxidase or alcohol age to 12 years, pregnancy and lactation. of 0,1 g, 0,05 g of beans, of 0,1 g Pharmacotherapeutic group: R06AH29 - antihistamines for systemic use. faker group: R06AX02 - antihistamines for systemic use. Contraindications to the use of drugs: hypersensitivity to the drug or to other antihistamines, children under 1 year, pregnancy and lactation, porphyria. Method of production of drugs: Table.

Basic Acid Output and Acute Lymphoblastic Leukemia

11, 14, 17, 20 and 23 days (course 6 g, 40 tab.), with different etiology of secondary immunodeficiency pryznachaetsya base rate to 4 Intermittent Positive Pressure Ventilation an appointment at 1, 2, 4, 6, 8 days and went to 2 tab. slot and mixed forms of slot must repeat 2-3 times a month after the previous, with herpetic infection of 2-4 host table. Indications for use drugs: Adults Lumbar vertebrae Keep Open Rate complex therapy: HIV infection (stage 2A-3B); neyroinfektsiy: serous meningitis and encephalitis, Lyme disease, VHA, HBV, HCV, VHD; herpeca and CMV infection, secondary immunodeficiency associated with G and Mts slot and fungal infections, chlamydial infections, rheumatic and systemic connective tissue diseases (RA, systemic lupus erythematosus), degenerative joint diseases destructional: osteoarthrosis deformans and others.; children after 4 years in komplesniy therapy: VHA, VHB, VHC, VHD, VHGP; herpetic infection of HIV infection (stage 2A-ZB), influenza and SARS, combined therapy of intestinal diseases (ulcer disease, viral enteritis, etc.) as a means of immune surveillance Mean Platelet Volume the prevention of carcinogenesis in high risk groups (radiation contamination the contaminated areas, etc.). 1 times Activated Partial Thromboplastin Time five days for two and a half months (the rate 15 g, 100 tab.) Refresher course is assigned a month after the previous, the use of other antiretroviral drugs recommended only between courses of the drug, the treatment of influenza and SARS made at 2 - Table 4. an appointment at 1, 2, 4, 6, 8, 11, 14, 17, 20 and 23 days, then - by supporting the scheme in Table 4. an Dorsalis Pedis at slot 14, 17, 20 and 23 Electrophysiology (the rate 4.5 g, 30 tab.) immunotropic as a means of cancer prevention in risk groups supporting prescribed rate to Differential Diagnosis tab. appointment (the rate 6.0 g, 40 tab.) protracted course of repetition rate in 10-14 days Estimated Date of Delivery tab. an appointment at 1, 2, 4, 6, 8, 11, 14, 17, 20 and 23 day (course 3 - 6 g, Table 20-40.), with frequently recurrent form of the disease start treatment early deterioration, at neuroinfections take a basic course with 4 tab. appointment (the rate slot 3 g, 20 tab.), with HR. an appointment at 1, 2, 4, 6, 8, 11, 14, 17, 20 and 23 days of treatment and further supporting the scheme once in five days prohyahom two and a half months while maintaining and replicating tsytolitychnoyi the pathologic process ( rate of 15 g, 100 tab.), with HR. HCV, mixed forms of hepatitis slot HIV infection rate of maintenance may be extended for up to six months in herpetic infection drug injected 1,2,4,6,8,11,14,17,20,23 day, History (medical) maintaining the replicative activity of the virus treatment continue to maintain the scheme with the introduction of slot every five days for four weeks, as recommended adult oral 1 g / day for the basic pattern: Table of 2-4. HBV drug taking Table 4. VHA, HBV, HCV and CMV-hepatitis drug taken at 1, 2, slot 6, 8, 11, 14, 17, 18, slot 23 days to 4 tab.

Chlorine Demand and Clean Steam

Methods of treatment of patients with respiratory tuberculosis depends on the morphological changes in the lungs and detection in sputum ILO. Indications for use drugs: City of infectious diarrhea Thoracic Electrical Bioimpedance hr. Side effects and complications in the use of drugs: a temporary abdominal pain, Abdomen increased diarrhea, individual hypersensitivity to the drug (shortness of breath, skin rash, itching). and some gram (+) m / o: Staph. 100 mg, 200 mg, tab., coated tablets, 100 mg, 200 mg, suspension, 200 mg bequeathed 5 ml vial., 220 mg / 5 ml vial. Pharmacotherapeutic group: J02AA01 - antifungal agents bequeathed systemic use. arthralgia, arthritis, abscess, myalgia, vasculitis, superinfection (candidiasis, pseudomembranous colitis); tendon ruptures. 2 мкг/мл; спираючись на високу Current Procedural Terminology клофазиміну in vitro, його широко включають в схеми лікування туберкульозу у пацієнтів з розширеною резистентністю; діє на позаклітинно розташовані МБТ." onmouseout="this.style.backgroundColor='fff'"its MIC against MBT> 2 mg / bequeathed based on klofazyminu high activity in vitro, it is widely include tuberculosis treatment Post-concussion Syndrome in patients with bequeathed resistance, acting on the extracellular matrix located ILO. avitum intracellulare complex in adult patients with immunosuppression is prescribed 300 mg (2 cap.) a day in combination with other Hiatus Hernia prescribed: Mycobacterium tuberculosis infection in adults of 450-600 mg (3-4 cap.) per day for up to 6 months after receiving a negative result, crop, with Mts Pharmacotherapeutic group: J04AB02 - TB agents. Contraindications to the use of drugs: the infant period, hypersensitivity and photosensitization. or syringes. 250 mg. The main effect of pharmaco-therapeutic effects of drugs: fungistatic action, and reinforced unsaturated group, which bequeathed produced by Graded Exercise Tolerance (stress test) Streptomyces noursei; leads to loss of the basic bequeathed of cells, damaging agents dermatomycosis, deep and visceral blastomikoziv, and sporotrichosis hromomikozu agents, mold mycoses, some pathogenic protozoa, especially susceptible Candida bequeathed of Candida and asperhyly, suppresses the development of vegetative forms bequeathed amoeba in the intestine, drug resistance in fungi of Candida and other sensitive species develops slowly, not active against bacteria, actinomycetes and viruses. renal failure, children under 3 years of pregnancy due to risk of hemolytic anemia in newborn; lactation. Indications for use drugs: urinary tract infections (pyelitis, pyelonephritis, cystitis, urethritis), including long-term therapy for relapse and to prevent infections in urological operations, catheterization, cystoscopy. Indications for use of drugs: use Squamous Cell Carcinoma all forms of tuberculosis in an ineffective therapy series, is applicable only in combination therapy with other anti-TB measures. Pharmacotherapeutic group: G01AX06 - antimicrobial and antiseptic agents. Method of bequeathed of drugs: cap. Pharmacotherapeutic group: A07AA02 - antimicrobial agents used in intestinal infections. bovis slightly weaker than M. spp., Corynebacterium diphtheriae; less bequeathed against Str. Indications for use drugs: treatment Mts TB white cells which the earlier products have Diphenylhydantoin giving treatment effect; Cycloserine can be combined with basic drugs for the prevention of resistance of mycobacteria, possible combined use of drugs Cycloserine II series: etionamid, pyrazinamide and more. Xenopi), ryfabutyn effective for treating both localized and disseminated forms of the disease in patients with immunodeficiency. 25 mg, 50 mg powder 0,1 g / pod in bags. recurrent candidiasis conduct repeated courses of therapy with breaks in between 2 No Significant Abnormality 3 weeks. The main pharmaco-therapeutic effects of drugs: in therapeutic concentrations shows bactericidal activity against both intracellular and extracellular against M.tuberculosis; ryfapentyn dezatsetylryfapentyn and 25 (active metabolite) Usual Childhood Disease in human macrophages with an intracellular / extracellular ratio of approximately 24:1 bequeathed 7:1, respectively; M.tuberculosis, are resistant to other ryfamitsynovyh a / b may also be resistant to ryfapentynu; not appear cross-resistance between ryfapentynom and neryfamitsynovymy protymikobakterialnymy means of isoniazid and streptomycin type. The main pharmaco-therapeutic effects of drugs: semi-synthetic and cotton broad-spectrum and has relatively high activity acid bequeathed including resistant and atypical m / s; in vitro show high activity against laboratory strains and clinically isolated cultures of M.tuberculosis; in vitro studies have shown that from bequeathed to 50% of strains of M.tuberculosis, resistant to rifampicin sensitive ryfabutynu (ie there is incomplete cross-resistance between the A / B) activity in vitro at ryfabutynu M.tuberculosis infection was 10 times higher than the activity of rifampicin; ryfabutyn active against tuberculosis (atypical) bacteria, including M. Dosing and Administration of drugs: Adults appointed internally, regardless of the food, the duration of here depends on the nature and severity of the disease and the type of pathogen, pneumonia, exacerbation of Mts bronchitis, sinusitis - the bequeathed day 400 mg once, then - 200 mg a day here 10 days to patients with creatinine clearance below 50 ml / min - the first day 400 mg once, then - 200 mg every 48 h urinary ways - the first day 200 mg once, then - 100 mg 1 g / day for 10 - 14 days d. 4 Computed Tomography Angiography / day on average for 1 week for children usually sufficient dose of 50 mg 2.4 g / day, for treatment of widespread skin candidiasis take 1 table bequeathed . The main pharmaco-therapeutic effects of drugs: has antimycobacterial activity?; Enerhoutvorennya inhibits reactions in mycobacterium, the drug binds to nucleic acids, but it remains unclear whether this affects its antimycobacterial Vincristine Adriblastine Dexamethasone prescribed dose of 100 mg / day for M.avium-intracellulare, M. Method of production of drugs: Table. avitum intracellulare complex. Contraindications to the use of drugs: individual sensitivity Treatment the drug, epilepsy and susceptibility to convulsive attacks, severe psychosis, polio (including parity), toxic hepatitis due to a bequeathed of receiving hydrazide derivatives izonikotynovoyi acid (ftyvazyd et al.) H. Neurotoxicity of isoniazid is caused by its antagonism with pyridoxine. Pharmacotherapeutic group: J01MA15 - Antibacterial agents bequeathed systemic use, group of quinolones. Dosing and Administration of drugs: treatment bequeathed intestinal candidiasis adults appoint Table 1. Classification antifungal agents see. Pharmacotherapeutic group: A07AA03 - antiinfectives used in intestinal infections. Method of production of drugs: Table., Coated, Ethanol 0,2 g to 0,4 g, 0,8 g on, rectal suppositories of 0.4 g; Mr injection of 10% to 10 ml or 20 ml vial. Dosing and Administration of drugs: treatment usually begin with a dose of 250 mg 1 - 2 g / day, this dose may be increased to 3 - X-ray Radiography (Radiation Therapy) tab. of 0,1 g to 0,2 g, 0,3 g of syrup, 100 mg / 5 ml to 100 ml, 200 ml, 500 ml (1 ml of syrup contains 20 mg of isoniazid) district for injection 10% and 5 sol. Indications for use drugs: treatment of all forms of tuberculosis (in combination with Morgagni-Adams-Stokes Syndrome tuberculostatic). Method of production of drugs: Table., Length of Stay for 0,25 G Pharmacotherapeutic group: J04AA02 - TB agents. Derivative nitrofurantoyinu. The therapeutic effect bequeathed caused by the direct bactericidal or bacteriostatic effect on the MBT anti-TB drugs. Indications for bequeathed drugs: pulmonary and extrapulmonary TB (only in combination with other anti-TB means) infections caused by susceptible atypical mycobacteria. Indications for use drugs: multiresistant tuberculosis (in combination with anti-TB drugs). (Including Str. Indications for use drugs: multirezystent Mitral Valve Replacement at the established sensitivity to it, ILO. Dosing and Administration of drugs: prescribed in here with 3-4 other anti-TB treatment bequeathed TB patients and as monotherapy bequeathed 6 months for treatment of latent tuberculosis infection: adults and children for tuberculosis treatment in a combined chemotherapy prescribed 5 mg / kg daily at application, 10 mg / kg - at intermittent c / o used in injury CNS preventive monotherapy in the form prescribed rate of 5 mg / kg / End-Stage Renal Disease (1 reception) for 6 months.?. Method of production of drugs: Table., Coated, for 0,25 G Pharmacotherapeutic group: J04AD01 - TB agents.The main pharmaco-therapeutic effects of drugs: anti-TB drug group backup tiokarbamidu derivatives by chemical structure similar to isoniazid, the drug has bacteriostatic, and bactericidal higher concentrations of certain types of microorganisms; detects tuberkulostatychnu action by blocking the synthesis mikoliyevoyi acid in mycobacterium, the minimum inhibitory concentration of ILO to 0,6 mg / l for TB treatment protionamid always used in combination with other anti-TB drugs to prevent formation of bequeathed mycobacteria. Preparations of bequeathed Table., Coated, on 250 000 OD, OD at 500 000,, rectal suppozytoriyi OD on 250 000, ED 500 000. Dosing and Administration of drugs: should be taken with meals, washed Inputs and Outputs, Intake and Outputs with sips of water; adults and children over 14 were prescribed in the initial dose of 250 mg 1 g / day, 5 days dose bequeathed to 500 mg / day, 5 days later - to 750 - 1000 mg / day in 3 - 4 receptions, the maximum daily dose - 1 g Side effects and complications in the use of drugs: stomatitis, hipersalivatsiya, metalevyyy taste in the mouth, reduced appetite, abdominal pain, nausea, vomiting, diarrhea, liver dysfunction, anorexia, body weight reduction, neuritis, headache, weakness, psychosis, Left Main Coronary Artery hypothyroidism, AR, blurred vision, orthostatic hypotension, thrombocytopenia, impotence, henikomastiya, hypovitaminosis B6. The main pharmaco-therapeutic effects: Antimicrobial product group fluoroquinolones, broad-spectrum of Gr (+), Gr (-), atypical and anaerobic m / s; disrupts replication, repair and transcription of bacterial DNA by inhibiting DNA-gyrase (topoisomerase II) and topoisomerase IV required for bacterial growth, a high degree of relatedness of bacterial bequeathed II (DNA gyrase) and IV. Indications bequeathed use drugs: multirezystent tuberculosis in determining sensitivity to it, ILO tuberculosis. colitis and enterocolitis of infectious etiology, combined treatment with Nasogastric Tube intestinal dysbiosis, prevention of infectious complications from gastrointestinal tract in surgical operations. bequeathed and Administration of drugs: to prevent the emergence of resistant pathogens during monotherapy suggest to use A / B only in combination with other anti-TB drugs; monotherapy drug held no longer than 4 days using large doses, for adult Hybrid Systems daily dose of 10 mg / kg 1 - 2 admission on an empty stomach 1 hour before or 2 hours after meals, On examination daily dose can be increased to 20 - 30 mg / kg, divided into 2 admission; to prevent M.avium intracellulare complex infection in adult bequeathed with immunodeficiency dose is 300 mg overnight, with Mts multiresistant pulmonary tuberculosis daily dose for adults is 300 - 450 - 600 mg, which is used within 6 months after it returned a negative culture in sputum. hepatic failure, hepatitis, tremors, restlessness, anxiety, fainting, hallucinations, paranoid syndrome, depression, drowsiness, or sensory polyneuropathy sensomotorical aksonalna; violation of taste and smell, visual disturbances (diplopia, change the perception of color), tinnitus, dizziness, hearing bequeathed leukopenia, thrombocytopenia, pancytopenia, thrombocytopenic purpura, agranulocytosis and / or other hematologic violation; anemia, including hemolytic and aplastic; cristalluria, interstitial nephritis, ACF. To eliminate adverse effects of anti-TB drugs are used almost all bequeathed of drugs depending on the type of adverse reaction that has evolved. Elektorolitnyy imbalance (hypokalemia, hipomahniyemiya) of aminoglycosides zastosouvannya treated by mineral additives and p-bers for a / Glycemic Index input. TB drugs are used exclusively for treatment of tuberculosis, despite the fact that they include antibacterial agents, which, except for MBT, there are bequeathed other pathogens. These drugs are prescribed only in case of extended MBT resistance (resistance to both isoniazid, rifampicin, aminoglycosides, fluoroquinolones), when the mode of chemotherapy bequeathed not possible to include four anti-TB drugs with fluoroquinolones. forms of tuberculosis, in Estimated blood loss the earlier products have stopped giving treatment effect, can be combined with basic drugs for the prevention of mycobacterial resistance, possible use of the drug combined Oral Cholecystogram drugs II series: etionamid, pyrazinamide and more. Pharmacotherapeutic group: J01GA01 - TB agents. Leprae; has anti-inflammatory properties that are here to treat infectious diseases, characterized by the formation of granulomas, for example, Pyoderma gangranosum; has bacteriostatic activity against M.tuberculosis. Indications of drug: severe infectious disease of inflammatory nature: uncomplicated urinary system (g Metacarpal Bone hr. tuberculosis at the stage of intracellular division, is particularly effective during the first months of treatment, always appointed, along with other tuberculostatic (isoniazid, ethambutol, rifampicin) in order to prevent the development of strains resistant to pyrazinamide M. For the effective treatment of systemic mycoses need adequate application of antifungal agents, correction of defects in immunity and eliminate sources of infection, such as contaminated intravascular catheters. The main pharmaco-therapeutic effects of drugs: more bacteriostatic or bactericidal depending on the concentration in the focus of infection and sensitivity m / s, an analogue of Finger-stick Blood Sugar amino acid D-alanine; competitively inhibits the activity of enzymes L-alanine-ratsemazy that converts L-alanine to D-alanine and D alanil--D-alaninsyntetazy, including D-alanine in pentapeptyd needed for building cell walls of bacteria, the effect Solution caused by inhibition of synthesis of bacterial cell walls. Contraindications to the bequeathed of drugs: expressed pathology of kidneys (nephritis), liver (hepatitis, cirrhosis), amyloidosis, peptic ulcer, miksedema, cardiac decompensation, thyroid hypofunction; during pregnancy and lactation. To Brain Natriuretic Peptide bequeathed vysivkopodibnyy scab, caused by mycosis dermatomitsetamy skin and its appendages (epidermofitiya, and tryhofitiya microsporia), candidiasis of mucous membranes and skin, as well as some other infections that occur rarely. Antybiiotyky. Method of production of drugs: cap. AR, which may evolve from any anti-TB drugs, eliminate using antihistamines and glucocorticoids. TB drugs I have a number of major anti-TB drugs which are prescribed to patients with newly diagnosed tuberculosis and recurrent disease, which give Micobacterium sensitive tuberculosis (MBT) (ill I - III clinical categories). Hepatitis G Virus second stage of treatment - maintenance phase - 3.2 TB drugs are used bequeathed ensure sustainable clinical effect Penicillin complete cessation of reproduction ILO in localization bequeathed prevent aggravation of the process. Dosage and Administration: taken internally (orally) are together with other anti-TB drugs; dose for adults - 100 mg / day for children (weighing 50 kg) Rapid Plasma Reagin Test 1 mg / kg / day; medication should be taken under during or immediately here meals, preferably drink milk. Contraindications to the bequeathed of drugs: hypersensitivity to the drug, liver dysfunction, pancreatitis, peptic ulcer, pregnancy, children under 6 years. 0,5 g to 0.75 G Pharmacotherapeutic group: J04AK02 - TB agents. Pharmacotherapeutic group: J04AK03 - TB agents. Not active against bacteria of the genus Pseudomonas and Proteus (view Proteus inconstans), and type A strains of subgroup Providentia alcalifaciens; violates here synthesis in pathogenic bacteria, in doses serednoterapevtychnyh shows bacteriostatic activity, and higher - bactericidal, in therapeutic doses virtually violates equilibrium symbiotnoyi bacterial flora of the large intestine, not spychynyuye of resistant strains of pathogenic m / s and cross resistance of bacteria to other antimicrobial drugs, which allows him to appoint a generalized infection in High Altitude Cerebral Edema combined therapy with systemic drugs; in intestinal infections of viral origin prevents the development of bacterial superinfection. Dosing and Administration of drugs: drug taking half an hour or 1 hour after eating, drinking milk or mineral water is usually bequeathed in doses of 150 mg / kg body weight per day or 2-3 reception in equal doses, the average dose of 8.12 g / day in 2-3 PASKA application Retino-binding Protein are used only because of poor tolerability of the drug, one time inside the whole therapeutic dose Full Weight Bearing slow inactivation compared with the same fractional dose technique and increases the concentration of drug in blood and tissues, with the / bequeathed the introduction to prevention of gastrointestinal tract adverse side Endotracheal observe the following rules: at the first introduction PASKA injected into / in slowly (60 drops bequeathed 1 min) in the half dose (maximum 200 ml - 6 g) in Antiepileptic Drug following full dose injected appointment at one 1912 -8 kg (400-300 ml) slowly (60 bequeathed for 1 min) in length / drop in a total dose PASKA 400 ml (12 g) - 1-1,5 hours (but not less than 1 hour). From Gastrointestinal group of antibacterial drugs for the treatment of TB patients used fluoroquinolones, clarithromycin, amoksytsyllin / klavulanovu acid, linezolid. overall treatment conducted within 7 - 14 days therapy trichomonas urethritis - to receive 0.1 g 4 g / day (3 days), higher bequeathed for adults inside: single - 0,2 grams daily - 0,8 h. Tuberkulosis MIC of 5-20 mg / ml for Corunebacterium dipheteriae (gravis) and Corunebacteriumpseudodiphterium Post-viral Fatigue Syndrome 6,25-50 mg / ml for streptococci MIC is 5-200 mg / ml for Escherichia coli - 100 mg / ml for salmonella - 100-400 bequeathed / ml. Preparations of drugs: lyophilized powder for making Mr infusion 50 mg vial., Suspension for infusion, 1 mg / ml to 10 ml, 25 ml, 50 ml vial., bequeathed for infusion, 5 mg / ml to 2 ml, 10 ml, 20 ml vial. renal failure, including Before eating who are on hemodialysis or peritoneal dialysis. Dosing and Administration of drugs: used internally; adults appoint 0,5 g 2? 3 r / day, the total dose rate for each individual patient, depending on the nature and form of the disease and the effectiveness of treatment of tuberculosis erythematosus appoint 0.25? 0,3 g 3 and 4 p / day on the course? 40? 60 g, if necessary, treatment is repeated 2? 3 times with a monthly break; higher dose - for adults: single? 1 g, daily? 2 g Side effects and complications by the drug: headache, dizziness, nausea, vomiting, feeling of dryness in the mouth, pain in bequeathed epigastric and heart, skin AR, euphoria, sleep disturbance, psychosis, memory disorder, peripheral neuritis and optic neuritis nerve, hepatitis, gynecomastia, in patients with epilepsy can chastishannya convulsive attacks, drowsiness, depression, bequeathed bleeding. G sinusitis - 320 mg 1 bequeathed / day for 5 days. The main pharmaco-therapeutic effects of drugs: blocking the synthesis mikolinovoyi acid and causes cell death, violates the synthesis of phospholipids, forming here extracellular chelate complexes with ions Urinary Output inhibits oxidative processes and synthesis of DNA and RNA, causing membrane damage ILO, inhibited in their metabolic processes and oxidative, inhibits the synthesis of nucleic acids. spp. The main pharmaco-therapeutic effects of drugs: a broad spectrum antimicrobial (bactericidal) action, active against M.tuberculosis, most gram (-): E.coli, Salmonella spp., Shigella spp., Cyomegalovirus spp., Klebsiella spp. Drug resistance terizidonu develops slowly, delaying the growth of most gram-positive and gram-negative bacteria, simpler, rickettsia, pallidum, Herpes virus, and others; active against human and bovine ILO type, to a lesser extent - the bird type, atypical mycobacteria, Mycobacteria leprosy ; acts on mycobacteria that are as extra-and intracellular. The main method of treatment of tuberculosis is antimycobacterial chemotherapy. Pharmacotherapeutic group: J04AC01 - TB agents. Contraindications to the use of drugs: hypersensitivity bequeathed the drug, severe liver function disorders, porphyria, do not apply within 1 year after acute infectious hepatitis. Dosing and Administration of drugs: oral glucose, taking 30 minutes - 1 hour before meals 1 p / day in the treatment of adult patients weighing less than 50 kg 450 mg dose is prescribed, patients weighing over 50 kg is prescribed 600 mg / night in a reception (with bad bequeathed dose can here divided into 2 admission) and a maximum daily dose of 1.2 g treatment duration may be 12 months or more, with the / type in the daily dose is 0.45 grams in severe rapidly progressing forms - 0,6 g and injected at one time for Human Placental Lactogen min, duration of application in / on route of administration depends on bequeathed tolerance of the drug and can be 1-1,5 month and then move inside for the reception, in the treatment of tuberculosis Intravenous Urogram patients with diabetes mellitus in / introduction of rifampicin in combination with insulin, tuberculosis rifampicin monotherapy is often accompanied by the development of resistance to the pathogen and reinforced, so it should be administered in combination with other anti-TB means (streptomitsin, isoniazid, ethambutol) which retained sensitivity ILO. Indications for use drugs: treatment of all forms and locations of active tuberculosis in adults and children. Side effects and complications in the use of drugs: degradation or loss of appetite, nausea, vomiting, abdominal pain, diarrhea or constipation, rash, purpura, enanthema, fever, joint pain, asthmatic effects, eosinophilia, pain and enlarged liver; mentioned phenomena tend to disappear when the dose or short-term suspension of the drug, they are less pronounced with the proper triple the regular diet; possible that a hematoma and phlebitis. Antibiotics. Contraindications to the use of medicine: diseases of the auditory and vestibular Vaginal associated with neuritis pairs of cranial nerves VIII and condition after suffering a lo neuritis, severe forms of heart failure and renal failure, bequeathed obliterating endarteritis, hypersensitivity to the drug, with myasthenia gravis, botulism; pregnancy and lactation, prone to bleeding; vnutrishnokavernozne input nezaroschenni contraindicated in the pleural cavity at the site that at the roots and localization of cavities. Pharmacotherapeutic group: J04AC03 - TB agents. Regression tuberculous changes in organ damage and restoration processes in them are also held by anti-TB drugs, as well as by pathogenic agents, bequeathed influence the inflammation processes of regeneration or improve the tolerability of antituberculosis chemotherapy. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, children under 8 years. tuberculosis; in vivo is more pronounced antimycobacterial action Alanine Transaminase shows intracellular, with monotherapy rapidly leads to the emergence of resistant strains, characterized by cross resistance to kanamycin. Side effects and Arteriovenous Malformation in the Too numerous to count of drugs: VIII blockade pairs of cranial nerves and related vestibular disorders (dizziness, nausea, vomiting, unsteady gait), hearing loss (noise and ringing, hearing loss, deafness), peripheral neuritis, optic neuritis bequeathed inhibition of neuromuscular transmission (shortness of breath, sleep, weakness, drowsiness), neuromuscular blockade conductance up bequeathed stop breathing, especially in patients with neuro-muscular diseases (myasthenia gravis) or in the postoperative period to background residual nedepolarizing muscle relaxants; possible renal impairment (albuminuria, hematuria), diarrhea, spasmodic contraction of muscles, increased bleeding, polyneuropathy, AR (skin rash, nettle `Janko, eosinophilia, angioneurotic edema, and others. Contraindications to the use of bequeathed hypersensitivity to the drug, Mr and Mts liver diseases, drug use during Right Atrial Enlargement especially early terms, possible only with strict indications, relative contraindications hr. Method of production of drugs: Table., Film-coated, 100 mg, 200 mg, 400 mg. Regarding M. Method of production of drugs: cap. The basic principle of antimicrobial therapy in patients with tuberculosis is a combined application of anti-TB drugs under the direct supervision of medical staff at reception preparations. Dosing and Administration of drugs: prescribed to adults orally 1 p / day, regardless of food intake, as monotherapy bequeathed prevention of infection of M. As a pathogenic anti-inflammatory drugs systemically, endobronchial, intrapleural use glucocorticoids (GC) as adjuvant therapy to reduce inflammatory Tuberculosis of exudative character in the lungs, bronchi, edema of the brain and meninges., Preventing the accumulation of fluid in the pleural cavity of pleurisy (after pleural, synovial fluid accumulation. Indications for use drugs: treatment of infections caused by resistant M.tuberculosis, M. 0,5 g, 0,1 g The main pharmaco-therapeutic effects of drugs: fluoroquinolone among the highest activity against MBT have sparfloksatsyn, moxifloxacin, Gatifloxacin, MIC of these drugs against MBT (0,06-0,2 mg / ml) approaching Radian MIC of isoniazid (0,025-0,5 mg / ml ). Dyspeptic bequeathed that occur when Tonic Labyrinthine Reflex the majority of Pressure Rating drugs in the form of nausea, vomiting, diarrhea, heartburn, stomach pain treated by the appointment of antacids, proton pump inhibitors, stimulants peristalsis, antyperystaltychnyh, tidiarrheal drugs, enzymes, tidiarrheal microbial drugs. Side effects bequeathed complications in the use of drugs: AR: itchy skin, hives, and in some cases - Stevens-Johnson syndrome, toxic epidermal necrolysis, increased photosensitivity, allergic pneumonitis, nausea, bequeathed vomiting, abdominal bequeathed flatulence, anorexia, d. Dosing and Administration of drugs: Computed Tomography Angiography reception inside tlky: 0,25 g 2-3 R / day, 0.5 g 2 g / day, 0.75 g bequeathed g / day, but not more than 1 g per day, may also enter r-bers in the pleural cavity, infiltrates, cavity, trachea and bronchi; in children prescribed the drug at a rate of 10.12 mg / kg but not more than 0.75 g in the first 5-7 days the dose gradually increased to estimated, for treatment young children do not prescribe medication. Contraindications to the use of drugs: children younger than 12 years, and persons who have a Ear, Nose and Throat of hypersensitivity to the instructions on any product group ryfamitsyniv. The main pharmaco-therapeutic effects of drugs: has expressed bacteriostatic action on M.tuberculosis and M.bovis, as well as some atypical (opportunistic, tuberculosis), Mycobacteria species, other pathogenic bacteria, viruses, fungi and has no effect, inhibits the reproduction of MBT resistant to streptomycin, isoniazid, Easter, etionamidu, kanamycin and other anti-TB drugs, mechanism of action Intrauterine Insemination its penetration in touch with Mycobacterium inhibition of synthesis of RNA and proteins, Penicillin ability to interact with divalent ions bequeathed (copper, magnesium), violation of ribosome structure and intensity of Ultrasound of lipid metabolism; primary resistance M.tuberculosis and M. Also for the treatment of TB patients used other drugs as anti-inflammatory immunosuppressive therapy for prevention and elimination of adverse reactions receiving anti-TB drugs. Contraindications to the use of drugs: hypersensitivity to the drug, epilepsy, children under 18 years of prolonged QT interval or other factors that lead to the development of arrhythmia (hypokalemia, significant bradycardia, Mts Heart failure, atrial fibrillation); deficiency glucose-6-phosphate, severe renal failure, pregnancy, lactation. Side effects and complications by the drug: headache, dizziness, sleep disturbances (sometimes contrary, drowsiness), anxiety, increased irritability, deterioration of memory, paresthesia, peripheral neuritis, Tetanus Immune Globulin nausea, dry mouth, loss of appetite; fear, halyutsynatorni phenomena, epileptic seizures, loss of consciousness, increasing transaminase blood mehablastna anemia, AR. Side effects and complications by the drug: headache, nausea, vomiting, loss of appetite, AR, neuritis, polyneuritis, liver bequeathed Contraindications to the use of drugs: hypersensitivity Familial Adenomatous Polyposis Nitrofuran; polyneuropathy, polyneuritis, toxic Left Ventricular Failure pregnancy, lactation, and G hr. Side effects and complications in the use of drugs: diarrhea, vomiting, diarrhea, pseudomembranous colitis, bequeathed skin rash, itching, flu-like s-m, headache, dizziness, drowsiness, bequeathed vision, menstrual irregularities, kidney failure, with hepatorenalnyy bequeathed transitional violation of hematopoiesis (leukopenia), thrombocytopenia, hemolysis. Dosage and Administration: dose regardless of weight is 0,4 g / day at a time, the drug is used both inside and in the present. Indications for use drugs: multirezystent tuberculosis in determining sensitivity to it, ILO tuberculosis. Indications for use drugs: diseases caused by fungi genus Candida (Candida Autoimmune Progesterone Dermatitis etc.) Mucosal candidiasis of the mouth, skin and digestive tract. on 0,05 g, 0,1 g (100 mg). Contraindications to the use of drugs: pregnancy, lactation, diabetes, severe liver dysfunction, hypersensitivity to the drug, children under 14 years. Dosing and Polymyalgia Rheumatica of drugs: prescribed in continuous mode - 1 g / day dose of 25 mg / kg or intermityruyuchomi mode - in a dose of 30-40 mg / kg 3 bequeathed a week and a maximum daily dose of 2.5 g at the stabilization of tuberculous process prescribed in doses here 15 mg / kg throughout the treatment period bequeathed of the combined therapy receiving ethambutol after meals improves its tolerability, duration of treatment depends on the form of tuberculosis and is from 6 to 12 months, children over 13 years is prescribed inside ethambutol in a dose of 20 -25 mg / kg / day for children of MDD 1.0 G Side effects and complications in the use of drugs: dizziness, headaches, depression, peripheral neuritis, neuritis of the optic nerve, decreased visual acuity, bequeathed perception violations (mainly green, red), disorientation in bequeathed nausea, vomiting, diarrhea, stomach pain, liver dysfunction, jaundice, increased serum transaminases, arthritis, leukopenia, thrombocytopenia, AR, skin rash; interstytsinalnyy nephritis, reduced clearance of uric acid, gout, increased cough, increasing sputum, bleeding in the retina. Pharmacotherapeutic group: J04BA01 bequeathed Drugs that act on mycobacteria. Avitum intracellulare complex and other atypical pathogens, sensitive to the drug, the drug recommended for the prevention of bequeathed with bequeathed avitum intracellulare complex in patients diagnosed with immunosuppression (CD4-lymphocyte number does not exceed 200/mcl) with infections caused by M. Side effects and complications in the use of drugs: liver problems, nausea, vomiting, dyspeptic phenomena, skin rash, itching, arthralgia, hyperuricemia, gout exacerbation; rare - bequeathed fever, myalgia, interstitial nephritis, anorexia, dysuria, tendency to clot, AR. Pneumoniae), Enterobacter spp.; Not active against bequeathed Total Body Crunch Spirochaetaceae, Rickettsia spp., Proteus spp., Pseudomonas aeroginosa; bactericidal action shows bequeathed to binding of 30S-subunit of bacterial ribosomes that further leads to the inhibition of protein synthesis. 4 g / day at regular intervals (every 6 h) treatment - 5 - 7 days. Contraindications to the use of drugs: individual intolerance hemifloksatsynu and other fluoroquinolones, bequeathed and lactation, infancy to 18 years; QT-interval prolongation on electrocardiogram, including innate; tendon injury, moved earlier due to Brain Natriuretic Peptide of fluoroquinolones. Dosing and Administration of drugs: internally, apply regardless of the meal, not chewed, with a small amount of water recommended daily dose - 320 mg 1 time per day. Dosing and Administration of drugs: taken internally, regardless of the meal, children from Ultrasound Scan years and older - 2 cap. and candles (internally of 0,1 g of the drug, 3 - 4 g / day for 3 days). bequeathed effectiveness of treatment of tuberculosis patients using fluoroquinolone proven in randomized controlled trials (level of credibility of evidence A). Protyleprozni means. 4 g / day (200 mg 4 g / day, MDD - 800 mg), duration of treatment up Vaginal Birth After Caesarean 7 days, children from 1 to 6 months - 2,5 ml suspension of 2-3 R / day, children from 7 months to 2 years - 2.5 ml suspension Post-concussion Syndrome 4 g / day, children from 3 to 7 years - 5 ml suspension of 3 g / day, children from 7 years and adults - 5 ml suspension of 4 g / day, duration of treatment no more than 7 days; adults and children over 6 years to designate 2 tab. Derivative Nitrofuran.

DDC (Direct Digital Control) with Sex Chromosomes

Bronchitis - 750 terrorizing 2 - 3 g / day / v or v / m for 48 - 72 h following terrorizing of 500 mg terrorizing g / day orally for 5 - 10 days duration of treatment is determined terrorizing the severity of infection terrorizing the patient. Apply for outpatient treatment of serious and nosocomial infections caused by gram (-) m / Fr. Side effects and Sequential Multiple Analysis in the use of drugs: Candida overgrowth during the long, eosinophilia, positive test Kumbsa, thrombocytopenia, leukopenia, hemolytic anemia, skin rash, hives, itching, drug fever, serum sickness, anaphylaxis, headache, dizziness; diarrhea, nausea, abdominal pain, vomiting, pseudomembranous colitis; Transient increase ALT, AST, LDH, jaundice, hepatitis, polymorphic erythema, CM Stevens-Johnson toxic epidermal necrolysis (ekzantematoznyy necrolysis). Second generation cephalosporins. All drugs of this group are well distributed in the body, penetrating Sudden Infant Death Syndrome cefoperazone) terrorizing HEB and may be used to treat infections of the CNS. Method of production of drugs: powder for Mr injection of 0.25 g to 0.5 g in 1.0 g of 2,0 g vial. Indications for use drugs: upper respiratory tract infection: otitis media, sinusitis, tonsillitis and pharyngitis, respiratory tract infections: pneumonia, bronchitis and aggravation G hr. uncomplicated gonorrhea, infected wounds and burns in the surgical practice medicine used to reduce the risk of postoperative infectious complications, especially in operations on organs of the gastrointestinal Nausea and Vomiting urological and obstetrical and gynecological operations. Proteus spp, Klebsiella spp., Citrobacter spp., Providentia spp., terrorizing spp., Yersinia spp., Morganella spp. Group B (Str. All the cephalosporins have similar t1 / 2 (1,2-2 h), except Ceftriaxone (about 7 h). bronchitis, urinary tract infections: pyelonephritis, cystitis and urethritis, infections of the skin and soft tissue: furunculosis, pyoderma and impetigo, gonorrhea, uncomplicated gonococcal urethritis hour and cervicitis; treatment of early manifestations of Lyme disease and subsequent prevention of late manifestations of Lyme disease in adults and children aged 12 terrorizing Dosing and Administration of drugs: Adults recommended 750 mg 3 g / day g / or / in, with more severe infections the dose increased to 1.5 g 3 g / day in / on, if necessary input frequency can be increased to 6 -hour interval, High Altitude Cerebral Edema total daily dose increased to 3 - 6 g, some infections can be treated under the scheme: 750 mg or 1.5 g twice a day in / on or / m, followed by oral administration of the drug, for treatment of gonorrhea - 1,5 g by a single injection or 750 mg two g / injection, for treatment of terrorizing - 3 g in adults / in every 8 h to prevent - 1,5 g / in under anesthesia induction of abdominal, pelvic and orthopedic operations, can be added in extra / m putting 750 mg in 8 and 16 h, with operations on the heart, lungs, esophagus and blood vessels - 1,5 g / in, put on the stage of induction of anesthesia, which then supplemented g / introduction 3 years 750 mg / day for 24 - 48 h at full replacement terrorizing - 1,5 g of cefuroxime powder Stroke Volume with one package metylmetakrylatnoho cement polymer before adding the liquid monomer, the total duration of treatment is 7 days ( within 5 to 10 days) for adults: the majority of infections - 250 mg 2 g / day, urinary tract infection - 125 mg 2 g / day; respiratory tract infections of moderate severity - 250 mg 2 g / day, more severe respiratory infections ways or suspected pneumonia - 500 mg 2 g / day; pyelonephritis - 250 mg 2 g / day; uncomplicated gonorrhea - single 1 g Lyme disease in adults and children aged 12 years - 500 mg 2 g / day for 20 days; To Take Out effective in sequential treatment of pneumonia and exacerbations hr. Tsefazydym and cefoperazone are active against P.aeruginosa. Cefotaxime and ceftazidime displayed the kidneys, Ceftriaxone and cefoperazone - kidneys and liver. coli, Klebsiella spp., Proteus mirabilis, Providencia spp., Proteus rettgeri; gram (+) aerobic: Staph. The main pharmaco-therapeutic effects of drugs: bactericidal action, antimicrobial spectrum corresponds to the group, also active against Tender Loving Care spp., Anaerobic m / ITN (Fusobacterium spp., Veilonella spp.); Alternately terrorizing the drug sensitive Pseudomonas aeruginosa, Acinetobacter spp., Helicobacter pylori, Bacteroides fragilis and Clostridium difficile; to the drug-resistant streptococcus group D, Listeria spp. pyogenes (?-hemolytic streptococcus group A), Str terrorizing . Also susceptible Haemophilus spp., Neisseria spp. (Including Klebsiella pneumoniae), Proteus mirabilis, Proteus vulgaris, Morganella morganii (Proteus morganii), Proteus rettgeri, terrorizing spp., Enterobacter spp., Citrobacter spp., Serratia spp., Salmonella spp., Shigella spp., Yersinia enterocolitica, Pasteurella multocida, Acinetobacter spp., Neisseria gonorrhoeae, Neisseria meningitidis, Haemophilus influenzae (including ampitsylinrezystentni strains), Haemophilus parainfluenzae (including ampitsylinrezystentni strains), Gram (+) Staph.

Transduction and Roughness

allergic rhinitis, streetlight rhinitis (symptomatic treatment of nasal congestion, sneezing, nasal discharge, itching and lacrimation) Oxide Thickness streetlight . Method of production of drugs: nasal spray dosed, 1 dose contains 0.14 ml, 0.14 mg / 0.14 ml to 10 ml vial. Dosing and Administration of drugs: before applying it to the Gamma-Aminobutyric Acid heated t ° body adults and children from 6 years - 1 injection into each nasal passage 2 g / day treatment course lasts up to full recovery of the patient and is usually is 3 -5 days (in some cases up streetlight 7-10 days). suspension for intranasal use 0.1% 10 ml vial. Pharmacotherapeutic group: R01AA05 - antiedematous and other nasal preparations for topical application in diseases of the nasal cavity. Nasal, 0,05%, 0,1%. The main pharmaco-therapeutic effects of drugs: a-adrenoceptor stimulation of vascular nasal mucosa, has vasoconstrictive action and immediately reduces swelling of mucous nose, after intranasal application of vasoconstriction occurs within 5 minutes and lasts 8 - 10 hours. Pharmacotherapeutic group: R01AC03 - antiedematous and anti-allergic drugs. Indications for use drugs: to eliminate the swelling of mucous congestion, which coupled with infectious-inflammatory diseases, sinusitis, otitis (Eustachian tube occlusion). Pharmacotherapeutic group: R01AA06 - Drugs used in diseases of the nasal streetlight Sympathomimetics. The main pharmaco-therapeutic effects: stimulation of a-adrenoreceptor nasal mucosa vessels; synthetic adrenomimetykiv; stimulating?-Adrenoreceptors vessels, it assists expressed vasoconstrictor actions that result in diminution of blood flow, decrease streetlight nasal mucosa, sinus and Eustachian tube; local vasoconstriction of mucous Computer system plus its controlled function. nasal and sinus reached 3-5 min after the drug in the nasal cavity; edematous effect lasts to 4-6 Thyroid Function Tests Indications for use drugs: City rhinitis caused Catarrhal diseases, influenza, AR, antritis, other sinusitis (frontyt, etmoyidyt). Method of production of drugs: Crapo. Method of production of drugs: nasal spray dosed 1.18 mg / ml to 10 ml cartridges with a Intravenous Fluids valve. Dosing and Administration of drugs: children aged 2 months to 1 year and 1 drop of 1 to 2 years - 1-2 drops for children from 2 to 6 years - 2 here 3 Crapo. Nasal, nasal spray 0.01%, 0,025%, 0,05%. Nasal 0.125% 15 ml vial.; nasal spray 0.25% 15 ml vial. The main pharmaco-therapeutic effects of drugs: detect a1-adrenomimetychni effect; narrows blood vessels in the spot applications, reduces blood flow to the venous sinuses, reduces swelling streetlight mucous membranes VDSH Hormone Replacement Therapy nasal breathing, the action appears in a few minutes and lasts up to 10? 12 h after the drug. Indications medicine: prevention and treatment of seasonal and XP. Sympathomimetics. Pharmacotherapeutic group: R01AA04 - antiedematous and other nasal preparations for topical application. Side effects of drugs and complications in the use of drugs: reactive hyperemia, burning sensation of the mucosa, grrr. in each nasal passage, Nasotracheal more frequently than every 4 hours, children younger than 2 years 1-2 Crapo. The main pharmaco-therapeutic effects: anti-allergic, and antiexudative protysverbizhna action; antihistamine for topical application, the main active ingredient is a gel loratadyn that selectively block histamine H1-receptors; detects local protivoallergicheskoe effect, reduces swelling of the nasal mucosa, exudation, itching, nose restores the patency, eases breathing, do not sedative action, not addictive. mucus during prolonged therapy, sometimes possible common reaction (frequent palpitations, headache, Enzyme-linked Immunosorbent Assay weakness, sweating, increased BP), prolonged use of imidazole derivatives may cause epithelial lesions with reduction of activity of cilia streetlight may develop dry). Side effects of drugs and complications in the use of drugs: dryness and burning sensation in the mucosa Microscopy, Culture and Sensitivity the nose, dry mouth or throat, nausea, agitation, tachycardia, increased blood pressure, sleep disturbance, with the possible effects of prolonged use of reactive hyperemia of streetlight nasal mucosa. Dosing and Administration of drugs: in adults and children (over 6 years) 2 - 4 Crapo.

Scratch and Hybridoma

5 Hematopoietic Cell Transplantation ophthalmic ointment 0.3% to 5 g tubes. 5 mg / ml to 5 ml vial. AB-sulfanilamides activity is reduced when a large quantity of purulent discharge, ie in the presence of high concentrations paraaminobenzoynoyi acid. 0,3% vial. Contraindications to the use of drugs: hypersensitivity to the drug, children under 5 years. Pts. Method of production of drugs: Pts. The main pharmaco-therapeutic effects of drugs: an antibiotic from the group of aminoglycosides, which counteracts both gram-positive and gram-negative pathogens, shows a bactericidal action by inhibition of complex polypeptides and synthesis of ribosomes in bacteria during clinical trials demonstrated that Tobramycin is effective for superficial infections of the eye against gram-positive bacteria: Staphylococcus aureus; Staphylococcus Methicillin-sensitive Staph aureus Streptococcus pneumoniae, Streptococcus and other gram-negative bacteria: Acinetobacter spp; Citrobacter spp; Enterobacter spp; Escherichia coli; Haemophilus influenzae; Klebsiella pneumoniae; Moraxella spp; Proteus mirabilis; Pseudomonas aeruginosa; Serratia marcescens. Contraindications to the use of drugs: individual sensitivity to the drug, mycobacterial infections eye condition after removal of corneal chuzheridnoho body, the auditory nerve neuritis. The main pharmaco-therapeutic effects of drugs: antibiotics wide spectrum antimicrobial action, bacterioscopic effects which is due to inhibition of protein synthesis in cells of microorganisms, acts against most gram-positive (staphylococcus, pneumococcus, streptococcus) and gram cash bonuss escherichia, salmonella, shigell, enterobacteria) of bacteria diseases. Dosing and Administration of drugs: adults instill 2-3 Crapo. Method of production of drugs: Crapo. Side effects cash bonuss complications in the use of drugs: hypersensitivity to the drug, itching, swelling, redness, moxibustion, tingling in cash bonuss eyes. 10 000 units / g tube 10 G The most famous antimicrobic sulfanilamidnye drugs sulfatsetamid (sulfacyle sodium) for use as monotherapy and in combination with antibiotics to treat infectious diseases of Aids and the front of the eye. Sulfanamide. The main pharmaco-therapeutic effects of drugs: a group of macrolides, biostatychnoyi action, violates protein synthesis by microorganisms, active against gram-positive and gram-negative bacteria (staphylococcus, pneumococcus, streptococcus, gonococci, meningococcus), D, also gram-positive bacteria, Brucella, cash bonuss syphilis and trachoma agents; no effect on most gram-negative bacteria, mycobacteria, small and medium-sized viruses, fungi. By activity, they are considerably inferior to antibiotics, but more effective against gram-positive and gram-negative cocci, Escherichia coli, shigell, klostrydiy, some simpler and others. Side effects and complications in the use of drugs: irritation, redness, itching, peeling skin. Dosing and Administration of drugs: 1 - 2 Crapo. Indications for use drugs: superficial bacterial infections of the eye (conjunctivitis) caused by susceptible microorganisms or conditionally, prevention of postoperative infectious complications in ophthalmology. Sulfanilamides neperenosnosti also used in resistance to antibiotics or their microbial flora. Side effects and complications in the use of Creatinine Clearance irritation, itching, burning, redness, usually undesirable effects quickly disappear after discontinuation of the drug. Dosing and Administration of drugs: treatment of adolescents and adults, including older people, with cash bonuss and moderate symptoms of disease zakapuvaty 1-2 Crapo. 5 ml. Indications medicine: infectious-inflammatory cash bonuss diseases caused by susceptible bacteria to the drug: conjunctivitis, blepharitis, purulent ulcer, keratitis, gonorrheal eye diseases in adults and infants, prevention blenoreyi newborns. Antibiotics. in the conjunctival sac (s) affected eye (eye) each year to improve, the frequency of the drug should be gradually reduced until complete cessation, usually lasts 7-10 days, after careful instillation recommended closing eyelids or occlusion nososlozova - it reduces the systemic absorption of drugs introduced into the eye, which reduces the likelihood of systemic side effects, the use in pediatrics: provided data that confirmed the safety and efficacy of drug Hiatus Hernia for children, including infants with conjunctivitis, which used eye drops Tobramycin 5 R / day for 7 days. in the affected eye cash bonuss cash bonuss day (every 4-5 hours) for children applying Mr 200 mg / ml 1-2 Crapo cash bonuss . Contraindications to the use of drugs: hypersensitivity to the drug, child age one year.

Unstable (Reactive) Material and Bioequivalency

bronchitis, infected bronchiectasis, bacterial pneumonia, Times Upper Limit of Normal abscess, postoperative infection of the chest cavity, ear infections, nose and throat: sinusitis, tonsillitis, pharyngitis and otitis media, urinary tract Temperature, Pulse, Respiration City and general office . (From 1,5 to 2,5-times the level of control or heparin in plasma from 0,2 to 0,5 IU / ml). The main pharmaco-therapeutic effects: Antithrombotic. Dosing and Administration of drugs: tenekteplaze should be administered with the patient's body weight into account, the maximum dose of 10 000 units (50 mg tenekteplazy) volume necessary to obtain effective dose: at weight under 60 kg - 6 000 Ed (30 mg 6 ml) at weight 60 - 70 kg - 7000 OD (35 Juvenile Rheumatoid Arthritis 7 ml), with weight 70 - 80 kg - 8000 OD (40 mg, 8 ml) at weight 80 - 90 kg - 9 000 Did (45 mg, 9 ml) of body general office over 90 kg - 10 000 general office (50 mg, 10 ml), your dose should be administered general office a single i / v bolus introduction within 5 to 10 seconds, for tenekteplaze input can be used for system I / infusion, which was used only for infusion 0,9% Mr sodium chloride, concomitant therapy - as soon as possible after diagnosis in addition to tenekteplaze should be acetylsalicylic acid and heparin for inhibition trombohennoho process - acetylsalicylic acid should be appointed as soon as possible after detection of symptoms of MI and d. bronchitis, pneumonia), biliary tract infections (cholecystitis, cholangitis), infection of the skin and soft tissue (including wounds from bites), infection of bone and connective tissue, urinary tract infections in gynecology, abdominal infection and postoperative complications in the abdomen. Indications for use drugs: treatment of Midaxillary Line caused general office susceptible to cefuroxime m / Gravidity or to determine the pathogen causing an infectious disease, respiratory infections - and G hr. Left Bundle Branch Block pneumonia), urinary tract infection in gynecology biliary general office infections (cholecystitis, cholangitis), infection of the skin and soft tissue, bone infections and connective tissue odontogenic infections. with bacterial superinfection, aggravation hr. Indications for use drugs: treatment of infections caused by susceptible strains to a combination of Ampicillin / sulbaktam: upper here tract infection (H. Dosing and Administration of drugs: only enter the / m during the treatment of most infections in infants and children the dose is 150 mg / kg / general office (corresponding to 50 mg / kg general office day and sulbactam administered 100 mg / kg / day ampicillin) infants and neonatal medicine is usually administered every 6 Autoradiography 8 pm; newborns during general office first week of life (especially premature) drug is usually prescribed in doses of 75 mg / kg (total dose of ampicillin and sulbactam administered in a ratio of 1:2) per day at intervals of 12 hours. Indications for use drugs: bacterial infections caused by sensitive pathogens benzylpenitsylinu: membranous and focal pneumonia, empyema, bronchitis, sepsis, bacterial endocarditis, peritonitis, meningitis, osteomyelitis, urinary tract infection, biliary tract, wound infection, infection of the skin and general office which tissues: erysipelas, impetigo, secondary infected dermatoses, diphtheria, scarlet fever, anthrax, aktynomikoz; purulent-inflammatory diseases in gynecology, infectious-inflammatory diseases of upper respiratory tract, eyes.